LCGC
BBP icon

Legacy Capital Group California’s Virtus Biotech ETF BBP Stock Holding History

Legacy Capital Group California’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,461
Closed -$498K – 270
2023
Q2 		$498K Buy
+9,461
New +$496K 0.2% 152

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
DSC
Duncker Streett & Co St. Louis, Missouri $526M AUM 22.2% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return

Legacy Capital Group California's BBP Position: Q3 2023 in Review

Legacy Capital Group California sold out of Virtus Biotech ETF (BBP) in Q3 2023, closing a stake of 9,461 shares — an estimated $498K sold.

Legacy Capital Group California first reported a position in BBP in Q2 2023 and held it in 1 quarter. The position peaked at $498K in Q2 2023. 11 funds tracked by Wall St. Rank hold BBP as of Q3 2023.

  • Legacy Capital Group California reported no remaining Virtus Biotech ETF position as of Q3 2023 after selling out during the quarter.
  • Legacy Capital Group California sold 9,461 Virtus Biotech ETF shares in Q3 2023, an estimated $498K.
  • Legacy Capital Group California first reported a position in Virtus Biotech ETF in Q2 2023 and held it in 1 quarter.
  • Legacy Capital Group California's Virtus Biotech ETF position peaked at $498K in Q2 2023.
  • 11 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2023.

Based on Legacy Capital Group California's 13F filing for Q3 2023, filed 6 Nov 2023.